vs
Side-by-side financial comparison of Lulu's Fashion Lounge Holdings, Inc. (LVLU) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Viridian Therapeutics, Inc.\DE is the larger business by last-quarter revenue ($70.6M vs $66.1M, roughly 1.1× Lulu's Fashion Lounge Holdings, Inc.). Lulu's Fashion Lounge Holdings, Inc. runs the higher net margin — -48.2% vs -49.0%, a 0.8% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs -11.8%). Lulu's Fashion Lounge Holdings, Inc. produced more free cash flow last quarter ($-2.6M vs $-84.7M).
Lulu's Fashion Lounge Holdings, Inc. is a direct-to-consumer women's fashion retailer offering affordable, trendy apparel, footwear, and accessories. It primarily serves Gen Z and millennial consumers across North America, operating mainly via its e-commerce platform, with limited pop-up physical locations to boost customer engagement.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
LVLU vs VRDN — Head-to-Head
Income Statement — Q4 FY2024 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $66.1M | $70.6M |
| Net Profit | $-31.9M | $-34.6M |
| Gross Margin | 37.9% | — |
| Operating Margin | -52.8% | -56.7% |
| Net Margin | -48.2% | -49.0% |
| Revenue YoY | -11.8% | 81958.1% |
| Net Profit YoY | -340.9% | 54.9% |
| EPS (diluted) | $-13.46 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $70.6M | ||
| Q4 24 | $66.1M | — | ||
| Q3 24 | $80.5M | — | ||
| Q2 24 | $92.0M | — | ||
| Q1 24 | $77.3M | — | ||
| Q4 23 | $83.1M | — | ||
| Q3 23 | $106.1M | — | ||
| Q2 23 | $91.0M | — |
| Q3 25 | — | $-34.6M | ||
| Q4 24 | $-31.9M | — | ||
| Q3 24 | $-6.9M | — | ||
| Q2 24 | $-10.8M | — | ||
| Q1 24 | $-5.7M | — | ||
| Q4 23 | $-3.9M | — | ||
| Q3 23 | $-2.6M | — | ||
| Q2 23 | $-5.6M | — |
| Q3 25 | — | — | ||
| Q4 24 | 37.9% | — | ||
| Q3 24 | 38.1% | — | ||
| Q2 24 | 45.5% | — | ||
| Q1 24 | 42.3% | — | ||
| Q4 23 | 40.3% | — | ||
| Q3 23 | 44.7% | — | ||
| Q2 23 | 41.7% | — |
| Q3 25 | — | -56.7% | ||
| Q4 24 | -52.8% | — | ||
| Q3 24 | -8.5% | — | ||
| Q2 24 | -4.9% | — | ||
| Q1 24 | -8.0% | — | ||
| Q4 23 | -5.9% | — | ||
| Q3 23 | -1.6% | — | ||
| Q2 23 | -6.5% | — |
| Q3 25 | — | -49.0% | ||
| Q4 24 | -48.2% | — | ||
| Q3 24 | -8.5% | — | ||
| Q2 24 | -11.7% | — | ||
| Q1 24 | -7.4% | — | ||
| Q4 23 | -4.7% | — | ||
| Q3 23 | -2.4% | — | ||
| Q2 23 | -6.2% | — |
| Q3 25 | — | — | ||
| Q4 24 | $-13.46 | — | ||
| Q3 24 | $-2.47 | — | ||
| Q2 24 | $-3.92 | — | ||
| Q1 24 | $-0.15 | — | ||
| Q4 23 | $-0.10 | — | ||
| Q3 23 | $-0.07 | — | ||
| Q2 23 | $-0.14 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.5M | $490.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $13.4M | $503.0M |
| Total Assets | $108.2M | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $490.9M | ||
| Q4 24 | $4.5M | — | ||
| Q3 24 | $6.3M | — | ||
| Q2 24 | $1.8M | — | ||
| Q1 24 | $5.5M | — | ||
| Q4 23 | $12.9M | — | ||
| Q3 23 | $5.9M | — | ||
| Q2 23 | $7.8M | — |
| Q3 25 | — | $503.0M | ||
| Q4 24 | $13.4M | — | ||
| Q3 24 | $43.8M | — | ||
| Q2 24 | $48.7M | — | ||
| Q1 24 | $57.7M | — | ||
| Q4 23 | $64.7M | — | ||
| Q3 23 | $64.7M | — | ||
| Q2 23 | $63.8M | — |
| Q3 25 | — | $577.1M | ||
| Q4 24 | $108.2M | — | ||
| Q3 24 | $153.5M | — | ||
| Q2 24 | $145.3M | — | ||
| Q1 24 | $160.6M | — | ||
| Q4 23 | $167.4M | — | ||
| Q3 23 | $164.7M | — | ||
| Q2 23 | $179.6M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $-84.6M |
| Free Cash FlowOCF − Capex | $-2.6M | $-84.7M |
| FCF MarginFCF / Revenue | -3.9% | -120.1% |
| Capex IntensityCapex / Revenue | 0.0% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $-84.6M | ||
| Q4 24 | $-2.5M | — | ||
| Q3 24 | $-5.5M | — | ||
| Q2 24 | $3.7M | — | ||
| Q1 24 | $6.9M | — | ||
| Q4 23 | $12.7M | — | ||
| Q3 23 | $4.6M | — | ||
| Q2 23 | $3.7M | — |
| Q3 25 | — | $-84.7M | ||
| Q4 24 | $-2.6M | — | ||
| Q3 24 | $-5.9M | — | ||
| Q2 24 | $3.4M | — | ||
| Q1 24 | $6.4M | — | ||
| Q4 23 | $12.1M | — | ||
| Q3 23 | $4.4M | — | ||
| Q2 23 | $3.2M | — |
| Q3 25 | — | -120.1% | ||
| Q4 24 | -3.9% | — | ||
| Q3 24 | -7.3% | — | ||
| Q2 24 | 3.7% | — | ||
| Q1 24 | 8.3% | — | ||
| Q4 23 | 14.5% | — | ||
| Q3 23 | 4.2% | — | ||
| Q2 23 | 3.5% | — |
| Q3 25 | — | 0.2% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | 0.7% | — | ||
| Q4 23 | 0.8% | — | ||
| Q3 23 | 0.2% | — | ||
| Q2 23 | 0.6% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LVLU
| Single Reportable Segment | $63.0M | 95% |
| Other | $2.4M | 4% |
| Stored Value Cards | $750.0K | 1% |
VRDN
Segment breakdown not available.
